Can a weekend retreat help prevent suicide in women veterans?

NCT ID NCT07738445

First seen Jul 31, 2026 ยท Last updated Jul 31, 2026

Summary

This pilot study tests a 3-day retreat program called GRIT, designed for women veterans who have experienced violence. The goal is to see if the retreat is acceptable and feasible, and whether it can improve social functioning as a way to reduce suicide risk. Participants are randomly assigned to either the in-person retreat or a self-guided version of the program. The study will compare outcomes like satisfaction, loneliness, and social functioning between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
GRIT, a 3-day in-person group retreat program
What this could lead to
If successful, this retreat-based program could offer a new way to reduce suicide risk by improving social connections among women veterans who have experienced violence.
What could go wrong
This is a small pilot study, so results may not apply broadly. The program's benefits are uncertain, and participation requires a significant time commitment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDE PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Suicide Prevention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Providence VA Medical Center, Providence, RI

    Providence, Rhode Island, 02908-4734, United States

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT

    West Haven, Connecticut, 06516-2770, United States

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT

    West Haven, Connecticut, 06516-2770, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.